Cargando…
Transitioning into GMP-Compliance: Alternative Methods for Producing Retinal Organoids for Transplantation
Three-dimensional retinal organoids derived from human induced pluripotent stem cells (hiPSCs) are gaining much attention as a possible source for cell transplantation to treat retinal degenerative conditions. However, the protocol for producing retinal organoids is time and labor intensive, involvi...
Autores principales: | Cobb, Hannah, Aparicio-Domingo, Silvia, Canto-Soler, M. Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362632/ https://www.ncbi.nlm.nih.gov/pubmed/34383873 http://dx.doi.org/10.1167/tvst.10.10.9 |
Ejemplares similares
-
Stem Cell Sources and Their Potential for the Treatment of Retinal Degenerations
por: Canto-Soler, Valeria, et al.
Publicado: (2016) -
A Surgical Kit for Stem Cell-Derived Retinal Pigment Epithelium Transplants: Collection, Transportation, and Subretinal Delivery
por: Li, Kang V., et al.
Publicado: (2022) -
Photoreceptor Transplantation in Late Stage Retinal Degeneration
por: Reh, Thomas A.
Publicado: (2016) -
Retinal Implantation of Electronic Vision Prostheses to Treat Retinitis Pigmentosa: A Systematic Review
por: Hallum, Luke E., et al.
Publicado: (2021) -
PDE5 says NO to cGMP
por: LeBrasseur, Nicole
Publicado: (2003)